Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecallantide for ACE Inhibitor Induced Angioedema
NCT01036659Phase 2Unknown
- Start
- May 2010
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ecallantide. Status: unknown.
02
Drugs
ecallantide
Beyond the preview
Go deeper on NCT01036659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01036659.